Please use this identifier to cite or link to this item:
Scopus Web of Science® Altmetric
Full metadata record
DC FieldValueLanguage
dc.contributor.authorParrella, A.en
dc.contributor.authorGold, M.en
dc.contributor.authorBraunack-Mayer, A.en
dc.contributor.authorBaghurst, P.en
dc.contributor.authorMarshall, H.en
dc.identifier.citationHuman Vaccines & Immunotherapeutics, 2014; 10(3):747-754en
dc.descriptionPubMed PMID: 24406315en
dc.description.abstractPassive reporting of adverse events following immunization (AEFI) by consumers or healthcare professionals is the primary mechanism for post-marketing surveillance of vaccine safety. Although recent initiatives have promoted consumer reporting, there is a lack of research concerning consumer reporters. Computer assisted telephone interviews (CATI) were conducted in 2011 of a cross-sectional, random, general population sample of 191 South Australian parents who stated that their children had previously experienced an AEFI. We compared awareness of surveillance, vaccine safety opinions, and demographics of parents reporting an AEFI to either healthcare professionals or surveillance authorities with those who did not report their children’s AEFI. Multivariate regression analyses measured: the association between reporting and safety views; and demographic predictors of reporting an AEFI. Reporting an AEFI to a healthcare professional or a surveillance authority was not significantly associated with awareness of a surveillance system. AEFI reporters, when compared with non-reporters, were more likely to be Australian-born (OR = 4.58, [1.64, 12.78], P = 0.004); were associated with the perception that a serious reaction was more likely to occur at their children’s last immunization (OR = 2.54 [95%CI 1.22, 5.30], P = 0.013); and were less accepting of the risk of febrile convulsion, (OR = 3.59 [95%CI 1.50, 8.57], P = 0.004). Although reporting an AEFI was not associated with awareness of surveillance or most socio-demographics, the results suggest some difference in safety opinions. Further studies are required to ascertain if these differences pre-date the occurrence of an AEFI or are a consequence of the AEFI and how consumers can contribute further to vaccine safety surveillance.en
dc.description.statementofresponsibilityAdriana Parrella, Michael Gold, Annette Braunack-Mayer, Peter Baghurst, and Helen Marshallen
dc.publisherLandes Bioscienceen
dc.rights©2014 Landes Bioscience.en
dc.subjectadverse event following immunization; vaccine safety attitudes; parent; health survey; surveillanceen
dc.titleConsumer reporting of adverse events following immunization (AEFI): Identifying predictors of reporting an AEFIen
dc.typeJournal articleen
dc.identifier.orcidGold, M. [0000-0003-1312-5331]en
dc.identifier.orcidBraunack-Mayer, A. [0000-0003-4427-0224]en
dc.identifier.orcidMarshall, H. [0000-0003-2521-5166]en
Appears in Collections:Paediatrics publications

Files in This Item:
There are no files associated with this item.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.